Individuals who suspect they have low testosterone or are at risk for diabetes should seek medical advice. The long-term risks of having both low testosterone and diabetes should not be overlooked. Some men may experience side effects, such as an increased risk of blood clots or sleep apnea. It is also important to note that diabetes can lead to low testosterone, especially in men who do not control their blood sugar well. There does appear to be a trend towards lower total testosterone and a diagnosis of ED. A challenge in making the diagnosis of testosterone deficiency is that many of the symptoms reported by patients are non-specific and might be related to conditions other than low testosterone. Total testosterone absence of signs and/or symptoms increases the likelihood of making a false diagnosis and reduces the potential benefit of testosterone therapy. Given that the direct method for free testosterone measurement is also time-consuming and labor intensive, calculation derived free testosterone measurement is more commonly used, however there is considerable variation in total testosterone assays as well as the clinical conditions that affect serum albumin and SHBG, all of which impact this measurement. The Panel recommends that clinicians use the same laboratory with the same method/instrumentation for serial total testosterone measurement. There is a great deal of variability across studies with respect to the forms of testosterone measured (total versus free), the assays utilized to measure testosterone, the time of day when the sample is obtained, and the number of testosterone measurements taken. As an example, a total testosterone value of 250 ng/dL may be considered low based on the current guideline but be marked within the normal range by the laboratory. Although confounders were accounted for in the analysis, concurrent medications that may have reduced the risk for myocardial infarction or other testosterone therapies used outside of the study protocol were not controlled for or assessed.Since the FDA warning in 2015, other studies have failed to demonstrate a risk of cardiovascular events in patients on testosterone therapy. In a 12-week study in 82 men, 72.6% of patients achieved a total testosterone concentration within the physiological range at steady state.434 Men treated with the agent were compared to a group of patients given 5 mg of a testosterone gel formulation, and no differences in mean testosterone serum levels were observed between the two groups.435 The study showed 92% of buccal versus 83% of gel patients achieved testosterone levels in the physiologic range. The goal of testosterone therapy is the normalization of total testosterone levels combined with improvement in symptoms or signs. Men with mild testosterone deficiency and whose weight is above the recommended range and/or who are physically inactive should be encouraged to consider low-risk lifestyle modifications followed by reassessment of testosterone levels, signs, and symptoms before deciding to start testosterone therapy. The cut-off of 300 ng/dL was chosen based on the mean total testosterone levels cited in the best available literature with a view to maximizing the potential benefit from prescribing testosterone while minimizing the risks of such treatment. When testosterone levels are low, the body’s ability to regulate insulin can be affected, leading to higher blood sugar levels.. The largest RCT conducted to date exclusively in men with T2DM is the BLAST study (an acronym of the towns and cities involved-Birmingham, Lichfield, Tamworth, Atherstone and Sutton Coldfield). The Moscow study involved 184 obese men randomised to long acting TU for 26 weeks found marked reductions in weight, BMI, waist circumference, and inflammatory markers but no reduction in fasting glucose . We therefore need alternative strategies as eventually many patients fail with a regime dedicated to lifestyle change and hypoglycaemic drugs.|Many factors can influence the level of testosterone at any given time including circadian rhythms, medications, and concomitant illness. In this clinical practice guideline, we outlined the challenges to making a diagnosis of hypogonadism, highlighting that there is debate as to the threshold testosterone level for diagnosing hypogonadism and whether it is the same for all target tissues (10). All women ultimately experience a drop in estradiol levels into the menopausal range.|Total testosterone levels were 2.1 ± 0.4 ng/mL for the baseline blood works. Correlation between insulin sensitivity (M) and serum testosterone (T) levels (A) and SHBG levels (B) in 60 men; 27 had NGT (□), 12 had IGT (△), and 21 had type 2 diabetes (•). We showed a positive correlation between serum testosterone levels and insulin sensitivity in men across the full spectrum of glucose tolerance (Figure 2A). In prospective studies, low testosterone levels have been shown to predict future development of T2DM. In a study of 74 men with a spectrum of glucose tolerance, we showed that administration of a standard 75 g glucose load caused a 25% decrease in testosterone levels 60 minutes after ingestion (11). To avoid over-treatment, it is important to recognize that approximately one-third of men with low testosterone levels have normal levels on repeat testing.} Patients on topical gels, patches, and intranasal formulations should have their testosterone checked between two to four weeks after commencement of therapy. For patients on daily medication, the Panel recommends that patients use medication the day of follow-up blood work. With respect to testosterone specifically, Grober et al. conducted an analysis of compounded testosterone creams/gels from 10 pharmacies in Toronto, Canada.410 Each pharmacy was given two prescriptions for 50 mg of testosterone, separated by 1 month to assess both intra-pharmacy and inter-pharmacy consistency. In 2001, the FDA performed an analysis of internet-purchased, compounded products following reports of contamination, poor compounding processes, and product toxicity.406, 407 Among 29 product samples analyzed, which included testosterone among multiple medications, 31% demonstrated sub-potency ranging from 59-89% below target dose. If the testosterone concentration is increased further, rather than further proliferation, the cells reduce their rate of proliferation.343, 344 This phenomenon is known as the bipolar testosterone concept. However, the saturation model introduced by Morgentaler is based on the concept that prostate cancer cells' response to the testosterone level to which they are exposed is not linear in nature. Given the increasing incidence of both testosterone deficiency and prostate cancer with advancing age, it is common for the two conditions to co-exist in older men. The other men in the study already had metastatic disease at the time of testosterone initiation. When both conditions are present, the risk of cognitive decline may be higher. Diabetes, especially if poorly controlled, can damage blood vessels in the brain, leading to problems with memory, thinking, and learning. Talking to a healthcare provider about these concerns can be the first step to improving mood and managing both low T and diabetes. People with low testosterone may experience symptoms like depression, irritability, and low energy.
